Short Genome Reports
Open Access

Complete Genome Sequence of a thermotolerant sporogenic lactic acid bacterium, Bacillus coagulans strain 36D1

  • Mun Su Rhee
  • , Brélan E. Moritz
  • , Gary Xie,
  • , T. Glavina del Rio
  • , E. Dalin
  • , H. Tice
  • , D. Bruce,
  • , L. Goodwin,
  • , O. Chertkov,
  • , T. Brettin
  • , C. Han,
  • , C. Detter,
  • , S. Pitluck
  • , Miriam L. Land
  • , Milind Patel
  • , Mark Ou
  • , Roberta Harbrucker
  • , Lonnie O. Ingram
  • and K. T. Shanmugam
Corresponding author
Standards in Genomic Sciences20115:3

DOI: 10.4056/sigs.2365342

© Rhee et al. 2011

Received: 22 December 2011

Published: 31 December 2011

Abstract

Bacillus coagulans is a ubiquitous soil bacterium that grows at 50-55 °C and pH 5.0 and ferments various sugars that constitute plant biomass to L (+)-lactic acid. The ability of this sporogenic lactic acid bacterium to grow at 50-55 °C and pH 5.0 makes this organism an attractive microbial biocatalyst for production of optically pure lactic acid at industrial scale not only from glucose derived from cellulose but also from xylose, a major constituent of hemicellulose. This bacterium is also considered as a potential probiotic. Complete genome sequence of a representative strain, B. coagulans strain 36D1, is presented and discussed.

Keywords:

Bacillus coagulansgenome sequencelactic acidfermentationprobioticsthermotolerant bacterium

Introduction

In addition to its use in food and cosmetics, lactic acid is increasingly used as a starting material for production of bio-based, renewable plastics [1-3]. Optically pure lactic acid required by the bioplastics industry is currently produced only by bacterial fermentation of sugars [3,4]. The main sugars currently used in such fermentations are glucose derived from corn starch or sucrose from sugar cane, sugar beets, etc. With increasing demand for renewable bio-based plastics, there is a shift away from food-based carbohydrates to non-food carbohydrates such as lignocellulosic biomass for lactic acid production [5,6]. Commercial fungal cellulases play a central role in the conversion of cellulose to glucose before fermentation to lactic acid and these enzymes function optimally at 50°C and pH 5.0 [7-10]. By matching the fungal enzyme activity optimum with that of the growth and fermentation optimum of the microbial biocatalyst, such as Bacillus coagulans, the amount of fungal cellulases required for simultaneous saccharification and fermentation (SSF) of cellulose to lactic acid can be reduced by a factor of three or higher compared to fermentation with lactic acid bacteria that grow optimally at temperatures below 40°C [9]. Since fungal enzymes represent a significant cost component of the overall process of biomass conversion to fuels and chemicals [11], reducing the enzyme loading during SSF of cellulose to lactic acid by B. coagulans is expected to lower the overall process cost and help the bioplastics industry compete with petroleum-based non-renewable plastics.

Bacillus coagulans belongs to a group of bacteria classified as sporogenic lactic acid bacteria [12]. These facultative anaerobes ferment pentoses, a component of hemicellulose, to L(+)-lactic acid as the major fermentation product reaching yields of 90% and titers close to 100 g/L in about 48 hours [13,14]. In this regard, B. coagulans differs from other lactic acid bacteria, such as Lactobacillus, Lactococcus, etc., in its ability to ferment pentose sugars to lactic acid through the pentose-phosphate pathway in contrast to the phosphoketolase pathway used by the lactic acid bacteria that yield an equimolar mixture of lactate and acetate [14]. Because of the thermotolerant, acid-tolerant and pentose fermentation characteristics, there is significant commercial interest in developing B. coagulans as a microbial biocatalyst for production of optically pure lactic acid as well as other fuels and chemicals. The higher operating temperature of B. coagulans is also expected to significantly reduce contamination of industrial fermentations that could lower product quality [15].

B. coagulans has been reported to function as a probiotic in animal trials and there is significant interest in the potential of this bacterium as a probiotic in humans [16]. These studies suggest that B. coagulans can readily achieve the GRAS (generally regarded as safe) status required for large scale industrial use. Genetic tools are being developed for manipulating B. coagulans, a genetically recalcitrant bacterium [17,18]. In order to fully explore the potential of B. coagulans as a microbial biocatalyst for production of fuels and chemicals, the entire genome of B. coagulans strain 36D1 was sequenced. Results from these experiments reveal that strain 36D1 has a single circular genome of 3,552,226 base pairs that encode 3,306 protein coding regions. Other characteristics of this bacterium, based on its genome composition, are presented and discussed.

Classification and features

B. coagulans was first isolated from coagulated milk by Hammer in 1915 [19]. Since then, several members of this group have been isolated from various sources [12,14]. B. coagulans strain 36D1 used in this study was isolated from a mud sample from an effluent stream of Old Faithful Geyser 1 near Calistoga, California, USA as an organism that can grow on xylose at 50°C and pH 5.0 both aerobically and anaerobically [14]. This bacterium is rod-shaped and produces endospore when cultured in nutrient broth (Fig. 1). Endospores are rarely observed when the bacterium was cultured in L-broth. Optimum temperature and pH for growth of strain 36D1 is 55°C and 5.5, respectively [10]. Corn steep liquor at 0.5% (w/v) provided the needed nutritional supplements for growth in mineral salts medium and the growth rate of the bacterium in that medium at 55°C was 1.67 h-1. The main fermentation product of the bacterium is L-lactate. Pentose fermentation increases the level of acetate, ethanol and formate in the medium compared to hexose fermentation [14]. Anaerobic cultures started with sparging of the medium with N2 require CO2 for growth. Other characteristics of the bacterium are listed in Table 1. B. coagulans strain 36D1 is deposited in the American Type Culture Collection (PTA-5827).

Fig. 1

Thin section electron micrographs of B. coagulans strain 36D1. Left: vegetative cell. Upper right: sporulating cell. Lower right: mature spore.

Table 1

Classification and general features of Bacillus coagulans strain 36D1

MIGS ID

    Property

     Term

      Evidence code

MIGS-2

    Classification

     Domain Bacteria

      TAS [20]

     Phylum Firmicutes

      TAS [21-23]

     Class Bacilli

      TAS [24,25]

     Order Bacillales

      TAS [26,27]

     Family Bacillaceae

      TAS [26,28]

     Genus Bacillus

      TAS [26,29,30]

MIGS-3

     Species Bacillus coagulans

      TAS [12,19,26]

     Strain 36D1

    Gram stain

     Positive

      IDA

    Cell shape

     Rods

      IDA

    Motility

     Yes

      IDA

    Sporulation

     Yes

      IDA

    Temperature range

     Thermotolerant; 30 – 60 °C

      TAS [10]

    Optimum temperature

     55 °C

      TAS [10]

MIGS-22

    Oxygen requirement

     Facultative anaerobe

      TAS [14]

 

    Carbon source

     Glucose, xylose, arabinose, galactose, maltose,     fructose, cellobiose, yeast extract, peptone

      IDA

 

    Energy source

     Organic carbon compounds

      IDA

    Terminal electron acceptor

     O2, acetate, pyruvate

      TAS [14]

MIGS-6

    Habitat

     Soil

      TAS [14]

MIGS-15

    Biotic relationship

     Free-living

      TAS [14]

MIGS-14

    Pathogenicity

     None; potential probiotic

      NAS

    Biosafety level

     1

      NAS

    Isolation

     Soil

      TAS [14]

MIGS-4

    Geographic location

     Near Calistoga, California, USA

      TAS [14]

MIGS-5

    Sample collection time

     2000

       IDA

MIGS-4.1

    Latitude

     38.58 N

      NAS

MIGS-4.2

    Longitude

     -122.58

      NAS

MIGS-4.3

    Depth

     Surface

      TAS [14]

MIGS-4.4

    Altitude

     351’

      NAS

TAS, traceable author statement; IDA, inferred from direct assay; NAS, non-traceable author statement. These evidence codes are from the gene ontology project [31].

The B. coagulans group is polydisperse [12] and among the Bacillus spp., strain 36D1 is phylogenetically close to B. halodurans based on 16S rRNA(DNA) sequences (Fig. 2). Although B. coagulans is similar to lactic acid bacteria in its ability to grow anaerobically and ferment sugars to lactic acid, it is distinct from the lactic acid bacteria based on 16S rRNA(DNA) sequence similarity.

Fig. 2

Unrooted phylogenetic tree based on 16S rRNA(DNA) of B. coagulans strain 36D1 and Bacillus spp. and Lactobacillus spp.

Genome sequencing and annotation

Genome project history

This genome was selected for sequencing on the basis of the properties described above. The genome sequence is deposited in GenBank (Accession number, CP003056). Sequencing was initiated and completed to a level of four contigs and annotated by the DOE Joint Genome Institute (JGI). The original draft version was deposited in GenBank on February 7, 2007 and the final draft version with four contigs was deposited on Feb. 3, 2010, thereby updating previous releases to the database. Genome sequencing was completed at the University of Florida, annotated by the Oak Ridge National Laboratory, and processed by the Los Alamos National Laboratory and NCBI. A summary of the project information is shown in Table 2.

Table 2

Genome sequencing project information

MIGS ID

     Property

    Term

MIGS-31

     Finishing quality

    Finished

MIGS-28

     Libraries used

    Genomic libraries: Sanger (one each of 2.5, 8 and 37 kbp library);    one 454CT library (2 kb); PCR; primer walk

MIGS-29

     Sequencing platforms

    Sanger; 454

MIGS-31.2

     Sequencing coverage

    9×

MIGS-30

     Assemblers

    Phrap, Newbler

MIGS-32

     Gene calling method

    Prodigal

     Genome Database

    GenBank

     INSDC ID

    CP003056

     Genbank Date of Release

    September 26, 2011

     GOLD ID

    GC01988

     NCBI project ID

    15679

MIGS-13

     Source material identifier

    ATCC PTA-5827

     Project relevance

    Biotechnological

Growth conditions and DNA isolation

B. coagulans strain 36D1 was cultured in LB + glucose (10 g/L) medium (pH 5.0) at 50°C in a shaker at 200 RPM as described before [10]. Cells were harvested during mid-exponential phase of growth. Cell pellet from a 30 ml culture was resuspended in 2.1 ml of TE buffer (Tris, 10 mM; EDTA, 10 mM; pH 8.0) supplemented with lysozyme (1 mg/ml; Sigma Chemical Co., St. Louis, MO, USA) and RNase (0.1 mg/ml; Sigma Chemical Co.). The sample was incubated at 37°C for 20 minutes to remove the cell wall. Sodium dodecyl sulfate (SDS) was added to the lysed cells to achieve an SDS concentration of 1.4%. After 10 minutes on ice, the lysate was extracted with equal volume of TE-saturated phenol to remove cellular debris. After two more extractions of the aqueous phase with equal volumes of phenol-chloroform mixture (25:24:1 of phenol, chloroform and isoamyl alcohol), and one extraction with an equal volume of chloroform:isoamyl alcohol, the DNA was precipitated with ethanol and dried. The ratio of absorbance at 260 nm and 280 nm of the purified DNA was 1.99 and based on agarose gel electrophoresis and ethidium bromide staining, DNA contained only a trace amount of degraded RNA.

Genome sequencing and assembly

The genome was sequenced using a combination of Sanger and 454 sequencing platforms. General aspects of library construction and sequencing can be found at the JGI website [32]. 454 pyrosequencing reads were assembled using the Newbler assembler version 1.1.02.15 (Roche). Large Newbler contigs were broken into 2 kb overlapping fragments (1 kb overlap) and entered into assembly as pseudo-reads. The sequences were assigned quality scores based on Newbler consensus q-scores with modifications to account for overlap redundancy and to adjust inflated q-scores. A hybrid 454/Sanger assembly was made using the Phrap assembler. Possible mis-assemblies were corrected with Dupfinisher or transposon bombing of bridging clones. Editing in Consed, custom primer walk or PCR amplification closed gaps between contigs. A total of 2,471 Sanger finishing reads were produced to close gaps, to resolve repetitive regions, and to raise the quality of the finished sequence. The error rate of the completed genome sequence was less than 1 in 100,000. Together all sequence types provided 9 x coverage of the genome. The final assembly contains a total of 35,357 Sanger and pyrosequence reads. This analysis yielded four contigs with lengths of 2,712, 65,471, 565,365 and 2,917,758 base pairs for a total of 3,551,306 base pairs.

In order to close the gaps, a restriction map of B. coagulans strain 36D1 genome was constructed using BglII restriction enzyme. This optical mapping by OpGen (Gaithersburg, MD) yielded a circular map of approximately 3,521 kbp. Comparing the computed restriction map of the DNA sequence from the four contigs with the restriction map of the whole genome, the lengths of the gaps between the appropriate contigs were predicted. Using the sequence information from the contigs and appropriate restriction fragments, PCR primers were synthesized and the genomic DNA was sequenced using Sanger method by the Interdisciplinary Center for Biotechnology Research at the University of Florida. As needed, PCR primers were synthesized based on new sequence information for genome walking to fill-in the gaps and complete the genome sequence. Based on these analyses, the genome of B. coagulans strain 36D1 was determined to be circular with a length of 3,552,226 base pairs.

Genome annotation

Genes were identified using Prodigal [33] as part of the Oak Ridge National Laboratory genome annotation pipeline. The predicted CDSs were translated and used to search the National Center for Biotechnology Information (NCBI) nonredundant database, UniProt, TIGRFam, Pfam, PRIAM, KEGG, COG, and InterPro databases. These data sources were combined to assert a product description for each predicted protein. Non-coding genes and miscellaneous features were predicted using tRNAscan-SE [34], RNAMMer [35], Rfam [36], TMHMM [37], and signalP [38].

Genome properties

The genome consists of a 3,552,226 bp long chromosome with a 46.5% GC content (Table 3, Fig. 3). Of the 3,420 genes predicted, 3,306 were protein coding genes, and 114 encode RNAs. Among the 114 RNA genes, 10 each coded for 5S, 16S and 23S rRNAs and 84 can be accounted for tRNAs.

Table 3

Genome statistics

Attribute

   Value

   % of total

Genome Size (bp)

   3,552,226

   100

DNA G+C content (bp)

   1,651,327

   46.5

Number of replicons

   1

Extrachromosomal elements

   0

Total genes

   3420

   100

RNA genes

   114

   3.3

Protein-coding genes

   3306

   96.7

Genes in paralog clusters

   541

   15.6

Genes assigned to COGs

   2456

   71.0

Genes with signal peptides

   858

   24.8

Genes with transmembrane helices

   863

   24.9

Paralogous groups

   199

   5.8
Fig. 3

Graphical circular map of the genome of B. coagulans strain 36D1. From outside to center: Genes on forward strand (color by COG categories), Genes on reverse strand (color by COG categories), pseudogenes, % G+C, GC skew.

The majority of the protein-coding genes (74%) were assigned with a putative function while those remaining were annotated as hypothetical proteins. About 49 ORFs were identified as potential transposases. The distribution of genes into COGs functional categories is presented in Table 4. The first about 40% of the genome is predominantly transcribed from the lagging strand (as written) while the other 60% is transcribed from the leading strand (Fig. 4).

Table 4

Number of genes associated with the general COG functional groups

Code

     Value

     %age

   Description

J

     172

     5.14

   Translation

A

     0

     0.00

   RNA processing and modification

K

     238

     7.11

   Transcription

L

     144

     4.30

   Replication, recombination and repair

B

     2

     0.05

   Chromatin structure and dynamics

D

     106

     3.16

   Cell cycle control, mitosis and meiosis

Y

     0

     0.00

   Nuclear structure

V

     113

     3.37

   Defense mechanisms

T

     162

     4.84

   Signal transduction mechanisms

M

     240

     7.17

   Cell wall/membrane biogenesis

N

     78

     2.33

   Cell motility

Z

     0

     0.00

   Cytoskeleton

W

     0

     0.00

   Extracellular structures

U

     50

     1.49

   Intracellular trafficking and secretion

O

     182

     5.44

   Posttranslational modification, protein turnover, chaperones

C

     277

     8.28

   Energy production and conversion

G

     310

     9.26

   Carbohydrate transport and metabolism

E

     379

     11.33

   Amino acid transport and metabolism

F

     100

     2.98

   Nucleotide transport and metabolism

H

     217

     6.48

   Coenzyme transport and metabolism

I

     104

     3.10

   Lipid transport and metabolism

P

     214

     6.39

   Inorganic ion transport and metabolism

Q

     168

     5.02

   Secondary metabolites biosynthesis, transport and catabolism

R

     448

     13.39

   General function prediction only

S

     242

     7.23

   Function unknown

-

   Not in COGs (Total – 3345)
Fig. 4

Principal component analysis based on COG profiles

Insights from genome sequence

Comparison of the predicted proteome of B. coagulans with that of a group of Bacillus spp genomes identified 491 unique proteins in B. coagulans that are not identified in other members of Bacillus spp. 404 of these genes are in the early part of the 36D1 genome as listed. This list includes 31 genes encoding putative transposases. Function of many of these gene products is not known. However, 413 of these unique proteins are found to be shared with Lactobacillus spp. In reverse, comparison of the B. coagulans genome with the genomes from a group of Lactobacillus spp. revealed that 423 ORFs are unique to B. coagulans and of these, 345 ORFs, mostly related to sporulation, are shared with Bacillus spp. Combining these two sets, a set of 78 ORFs coding for proteins with unknown function are unique to B. coagulans that are not present in either Bacillus or Lactobacillus. Based on principal components analysis, B. coagulans strain 36D1 groups with Bacillus but as an outlier and away from Lactic acid bacteria (Fig. 4). Although B. coagulans produced L-lactic acid as the fermentation product at an optical purity reaching close to 100%, the genome contains a gene encoding D-LDH.

Although some members of B. coagulans group are cellulolytic and xylanolytic, strain 36D1 is phenotypically unable to utilize cellulose and xylan. However, genes encoding glycan hydrolases such as xylanase, xylosidase and α-amylase can be identified in the genome sequence. Presence of these genes suggest that the bacterium can be evolved to produce xylanase to reduce the severity of acid treatment during hydrolysis of hemicellulose from lignocellulosic biomass for production of optically pure lactic acid. B. coagulans strain 36D1 is an auxotroph for several amino acids and vitamins. Based on analysis of the genome sequence by Patric Comparative pathway tool [39], only histidine biosynthetic pathway appears to be incomplete among the amino acid biosynthesis pathways. Among the vitamins, the pathways for biosynthesis of biotin, pantothenic acid, nicotinamide and pyridoxine appear to be incomplete.

During the time of preparation of this manuscript, genome sequence for B. coagulans strain 2-6 was published [40]. The genome of this strain is 3,073,079 and is 479,147 bp smaller than the genome of strain 36D1. These two B. coagulans genomes share about 90% or higher nucleotide sequence identity in the regions that are present in both genomes. Additional comparative analysis of the two genomes is in progress.

Declarations

Acknowledgements

This study was supported in part by a grant from the Department of Energy (DE-FG36-04GO14019 and DE-FG36-08GO88142), US Department of Agriculture, National Institute of Food and Agriculture (2011-10006-30358), the State of Florida, University of Florida Agricultural Experiment Station and Florida Energy Systems Consortium. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  1. Datta R and Henry M. Lactic acid: recent advances in products, processes and technologies - a review. J Chem Technol Biotechnol. 2006; 81:1119-1129 View Article
  2. Madhavan NK, Nair NR and John RP. An overview of the recent developments in polylactide (PLA) research. Bioresour Technol. 2010; 101:8493-8501 View ArticlePubMed
  3. Wee Y, Kim J and Ryu H. Biotechnological production of lactic acid and its recent applications. Food Technol Biotechnol. 2006; 44:163-172
  4. Hofvendahl K and Hans-Hagerdal B. Factors affecting the fermentative lactic acid production from renewable resources. Enzyme Microb Technol. 2000; 26:87-107 View ArticlePubMed
  5. Carole TM, Pellegrino J and Paster MD. Opportunities in the industrial biobased products industry. Appl Biochem Biotechnol. 2004; 115:871-885 View ArticlePubMed
  6. Mooney BP. The second green revolution? Production of plant-based biodegradable plastics. Biochem J. 2009; 418:219-232 View ArticlePubMed
  7. Abe S and Takagi M. Simultaneous saccharification and fermentation of cellulose to lactic acid. Biotechnol Bioeng. 1991; 37:93-96 View ArticlePubMed
  8. Iyer PV and Lee YY. Product inhibition in simultaneous saccharification and fermentation of cellulose into lactic acid. Biotechnol Lett. 1999; 21:371-373 View Article
  9. Ou MS, Mohammed N, Ingram LO and Shanmugam KT. Thermophilic Bacillus coagulans requires less cellulases for simultaneous saccharification and fermentation of cellulose to products than mesophilic microbial biocatalysts. Appl Biochem Biotechnol. 2009; 155:379-385 View ArticlePubMed
  10. Patel MA, Ou M, Ingram LO and Shanmugam KT. Simultaneous saccharification and co-fermentation of crystalline cellulose and sugar cane bagasse hemicellulose hydrolysate to lactate by a thermotolerant acidophilic Bacillus sp. Biotechnol Prog. 2005; 21:1453-1460 View ArticlePubMed
  11. Leber J. Economics improve for first commercial cellulosic ethanol plants. New York Times 2010:Feb. 16, 2010.
  12. De Clerck E, Rodriguez-Diaz M, Forsyth G, Lebbe L, Logan NA and DeVos P. Polyphasic characterization of Bacillus coagulans strains, illustrating heterogeneity within this species, and emended description of the species. Syst Appl Microbiol. 2004; 27:50-60 View ArticlePubMed
  13. Ou MS, Ingram LO and Shanmugam KT. L: (+)-Lactic acid production from non-food carbohydrates by thermotolerant Bacillus coagulans. J Ind Microbiol Biotechnol. 2011; 38:599-605 View ArticlePubMed
  14. Patel MA, Ou MS, Harbrucker R, Aldrich HC, Buszko ML, Ingram LO and Shanmugam KT. Isolation and characterization of acid-tolerant, thermophilic bacteria for effective fermentation of biomass-derived sugars to lactic acid. Appl Environ Microbiol. 2006; 72:3228-3235 View ArticlePubMed
  15. Abdel-Banat BMA, Hoshida H, Ano A, Nonklang S and Akada R. High-temperature fermentation: how can processs for ethanol production at high temperatures become superior to the traditional process using mesophilic yeast? Appl Microbiol Biotechnol. 2010; 85:861-867 View ArticlePubMed
  16. Drago L and De Vecchi E. Should Lactobacillus sporogenes and Bacillus coagulans have a future? J Chemother. 2009; 21:371-377PubMed
  17. Kovács AT, van Hartskamp M, Kuipers OP and van Kranenburg R. Genetic tool development for a new host for biotechnology, the thermotolerant bacterium Bacillus coagulans. Appl Environ Microbiol. 2010; 76:4085-4088 View ArticlePubMed
  18. Rhee MS, Kim JW, Qian Y, Ingram LO and Shanmugam KT. Development of plasmid vector and electroporation condition for gene transfer in sporogenic lactic acid bacterium, Bacillus coagulans. Plasmid. 2007; 58:13-22 View ArticlePubMed
  19. Hammer BW. Bacteriological studies on the coagulation of evaporated milk. Iowa Agric. Exp. Station Res. Bull.. 1915; 19:119-131
  20. Woese CR, Kandler O and Wheelis ML. Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc Natl Acad Sci USA. 1990; 87:4576-4579 View ArticlePubMed
  21. Gibbons NE and Murray RGE. Proposals Concerning the Higher Taxa of Bacteria. Int J Syst Bacteriol. 1978; 28:1-6 View Article
  22. Garrity GM, Holt JG. The Road Map to the Manual. In: Garrity GM, Boone DR, Castenholz RW (eds), Bergey's Manual of Systematic Bacteriology, Second Edition, Volume 1, Springer, New York, 2001, p. 119-169.
  23. Murray RGE. The Higher Taxa, or, a Place for Everything...? In: Holt JG (ed), Bergey's Manual of Systematic Bacteriology, First Edition, Volume 1, The Williams and Wilkins Co., Baltimore, 1984, p. 31-34.
  24. . List of new names and new combinations previously effectively, but not validly, published. List no. 132. Int J Syst Evol Microbiol. 2010; 60:469-472 View Article
  25. Ludwig W, Schleifer KH, Whitman WB. Class I. Bacilli class nov. In: De Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer KH, Whitman WB (eds), Bergey's Manual of Systematic Bacteriology, Second Edition, Volume 3, Springer-Verlag, New York, 2009, p. 19-20.
  26. Skerman VBD, McGowan V and Sneath PHA. Approved Lists of Bacterial Names. Int J Syst Bacteriol. 1980; 30:225-420 View Article
  27. Prévot AR. In: Hauderoy P, Ehringer G, Guillot G, Magrou. J., Prévot AR, Rosset D, Urbain A (eds), Dictionnaire des Bactéries Pathogènes, Second Edition, Masson et Cie, Paris, 1953, p. 1-692.
  28. Fischer A. Untersuchungen über bakterien. Jahrbücher für Wissenschaftliche Botanik. 1895; 27:1-163
  29. Cohn F. Untersuchungen über Bakterien. Beitr Biol Pflanz. 1872; 1:127-224
  30. Gibson T, Gordon RE. Genus I. Bacillus Cohn 1872, 174; Nom. gen. cons. Nomencl. Comm. Intern. Soc. Microbiol. 1937, 28; Opin. A. Jud. Comm. 1955, 39. In: Buchanan RE, Gibbons NE (eds), Bergey's Manual of Determinative Bacteriology, Eighth Edition, The Williams and Wilkins Co., Baltimore, 1974, p. 529-550.
  31. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS and Eppig JT. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25:25-29 View ArticlePubMed
  32. . Web Site
  33. Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW and Hauser LJ. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics. 2010; 11:119 View ArticlePubMed
  34. Lowe TM and Eddy SR. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 1997; 25:955-964 View ArticlePubMed
  35. Lagesen K, Hallin P, Rodland EA, Staerfeldt HH, Rognes T and Ussery DW. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 2007; 35:3100-3108 View ArticlePubMed
  36. Griffiths-Jones S, Bateman A, Marshall M, Khanna A and Eddy SR. Rfam: an RNA family database. Nucleic Acids Res. 2003; 31:439-441 View ArticlePubMed
  37. Krogh A, Larsson B, von Heijne G and Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001; 305:567-580 View ArticlePubMed
  38. Bendtsen JD, Nielsen H, von Heijne G and Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol. 2004; 340:783-795 View ArticlePubMed
  39. Patric Comparative pathway tool. Web Site
  40. Su F, Yu B, Sun J, Ou HY, Zhao B, Wang L, Qin J, Tang H, Tao F and Jarek M. Genome sequence of the thermophilic strain Bacillus coagulans 2-6, an efficient producer of high-optical-purity L-lactic acid. J Bacteriol. 2011; 193:4563-4564 View ArticlePubMed

Standards in Genomic Sciences

ISSN: 1944-3277

Contact us